MedPath

SURGACOLL TECHNOLOGIES LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Assessment of HydroxyColl Bone Graft Substitute in High Tibial Osteotomy Wedge Grafting.

Not Applicable
Conditions
Osteoarthritis, Knee
First Posted Date
2018-07-26
Last Posted Date
2018-07-26
Lead Sponsor
SurgaColl Technologies Limited
Target Recruit Count
40
Registration Number
NCT03601130
Locations
🇬🇧

Basingstoke & North Hampshire Hospital, Basingstoke, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.